Euphytose

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Euphytose

Quick Facts

Property Description
Active Ingredients Extracts of Valerian, Passion Flower, Hawthorn, and Ballota
Form Oral film-coated tablet
Pharmacological Class Mild Sedative and Anxiolytic (Nervine)
Common Use Relief from nervous states and tension
Origin Traditional Herbal Medicinal Product (Phytomedicine)

What Type of Medicine is Euphytose and What is its Classification?

Euphytose is defined as a traditional compound phytomedicine, classifying it as an established product made from a fixed, synergistic combination of multiple plant-based extracts. It belongs to the pharmacological class of mild sedatives and anxiolytics (calmative agents), functioning as a nervine to gently influence the central nervous system. Its regulatory status as a Traditional Herbal Medicinal Product confirms its natural origin and its therapeutic use based on established historical application. Unlike single-herb products, Euphytose is a combination product that utilizes four distinct botanical sources to achieve a more balanced effect, a formulation that is recognized for supporting a calming response during periods of increased stress.


Active Ingredients and Pharmaceutical Form

The proprietary active composition is derived from the extracts of four principal botanicals: Valerian (Valeriana officinalis), Passion Flower (Passiflora incarnata), Hawthorn (Crataegus species), and Ballota (Ballota foetida). These standardized extracts are prepared into the solid dosage form of an oral film-coated tablet, intended for administration via the oral route. There is an established traditional use of Valerian root for relieving mild nervous tension and aiding sleep. This confirms that the key components are recognized for their calming properties.


General Purpose and Indication for Euphytose

The overarching general purpose of Euphytose is to provide relief for minor symptoms related to mild nervous states and general tension by promoting relaxation, such as when a patient feels keyed up or irritable. The medicine's mild sedative action helps to reduce the physical and mental manifestations of nervous unrest. By gently easing the effects of daily stress, the medicine’s function is linked to supporting the establishment of more conducive sleep patterns when minor nervous agitation interferes with rest. This confirms that the traditional use of the active ingredients is linked to aiding sleep in times of stress. Euphytose is typically positioned as an over-the-counter (OTC) option for managing everyday stress responses.

Regulatory References

  1. EMA Herbal Medicines Overview

What side effects are possible with Euphytose?

Possible Side Effects and Safety Information

The safety profile for this medicine, a traditional herbal product, is based on the classification and frequency of adverse reactions documented in official regulatory labeling. These reactions are primarily classified in the Rare or Very Rare categories.


Officially Documented Adverse Reactions

The most commonly classified adverse reactions, designated as Rare (affecting 1 to 10 users in 10,000), relate to the Gastrointestinal System, presenting as digestive disorders, and the Skin and Subcutaneous Tissue, involving allergic skin reactions. The presence of certain excipients (parahydroxybenzoates) is also officially documented as a potential cause of allergic reactions.

The most significant and severe adverse reaction is liver disease, which is classified as Very Rare (affecting less than 1 user in 10,000). Official documents specify that this effect is particularly associated with use in children and when the recommended dosage is exceeded.


Population-Specific Safety Considerations

The official label defines specific constraints for certain groups. The medicine is contraindicated in children under six years of age due to the dosage form (coated tablet). Use is generally advised to be avoided during both pregnancy and breastfeeding. Furthermore, precautions are necessary for individuals diagnosed with hepatic impairment.

Additional restrictions apply to individuals with pre-existing metabolic conditions, requiring the medicine to be avoided in cases of fructose intolerance, glucose-galactose malabsorption syndrome, or sucrase-isomaltase deficiency due to excipient content. Official safety notes also advise caution regarding the potential for the product to alter vigilance.

Overdose and Emergency Response

Overdose and When to Seek Help

The official overdose profile for this product is structured based on the risk of consuming amounts exceeding the recommended dose, primarily concerning its valerian root component.

Documented Overdose Presentations

Regulatory sources indicate that an overdose, such as one involving approximately 20 grams of valerian root, is generally associated with temporary, benign symptoms. These may include:

  • Gastrointestinal Disturbances: Nausea, vomiting, abdominal cramps.
  • Neurological/Systemic Symptoms: Fatigue, lightheadedness, mild hand tremor, chest tightness, and pupillary dilation (mydriasis).

In rare cases, liver damage (hepatic disease) has been reported, particularly in children and when the recommended dosage was exceeded.

Overdose-Related Risk Factors (Official Labeling) Physiological Systems Affected
Exceeding the recommended dosage Gastrointestinal, Nervous, and Hepatobiliary Systems
Ingestion of very high doses over several years Nervous System (Reported delirium/withdrawal)

Emergency Actions and Urgent Medical Attention

Official labeling stresses that if symptoms arise following an overdose, the treatment should be symptomatic and supportive, meaning it aims to alleviate the symptoms while the body processes the substance. There is no specific, listed antidote.

Urgent medical attention is required if severe or concerning symptoms, such as signs of liver damage or persistent, intense gastrointestinal or neurological effects, are observed or suspected. Do not take a double dose to compensate for a missed dose.

Therapeutic Uses of Euphytose

What Euphytose Treats: Main Uses and Benefits

Euphytose is commonly used to help manage mild nervous states and psychic tension that arise from common pressures, such as feeling keyed up, minor irritability, or mental unrest. The combination of herbs contained in this type of product is relevant for easing mild symptoms of mental stress and supporting sleep.

“The product helps ease the overall symptom load, and is not intended to treat severe clinical conditions.”

The primary therapeutic domain is applicable within clinical settings that involve transient, non-severe nervous tension, somatic restlessness, and sleep-initiation difficulties due to agitation. The product is commonly used to help with symptoms related to increased neurological or muscular activity, which often manifest as general restlessness and inability to achieve physical relaxation during periods of tension. In these contexts, the medicine may assist with maintaining a sense of stability when symptoms are more noticeable, supporting the patient during difficult episodes by easing distress and contributing to improved comfort.

Quick Fact: Symptomatic Relief
Primary Symptom Pattern Psychic tension, irritability, and restlessness linked to everyday stress.
Symptom Severity Mild or minor, episodic manifestations.
Core Benefit Supportive relief that helps ease the overall symptom burden.

Eligibility and Restrictions for Use

Official Eligibility Profile: Who Can and Cannot Use Euphytose?

This eligibility profile is defined by official government regulatory documents (e.g., ANSM, France) and dictates the conditions under which the traditional herbal medicine may or may not be used.

Populations Strictly Prohibited (Contraindicated)

Use of this medicine is strictly contraindicated in several specific populations:

  • Individuals with a known hypersensitivity or allergy to any of the active substances (Valerian, Passionflower, Hawthorn, Ballota) or any other components (excipients).
  • Children under 6 years old, due to the specific pharmaceutical form (coated tablet).
  • Patients with specific hereditary metabolic diseases, including fructose intolerance, glucose-galactose malabsorption syndrome, or sucrase-isomaltase deficiency, due to the presence of sucrose.

Restricted or Non-Recommended Use

  • Pregnancy and Breastfeeding: Use is generally not recommended or must be avoided due to a lack of sufficient, established safety data for these physiological states.
  • Functional Safety: Caution is required for all users as the medicine may cause drowsiness. Individuals must not drive or operate machinery if they experience this effect, establishing a functional restriction on use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The regulatory documentation defining the interaction profile for this compound herbal preparation centers on the potential for pharmacodynamic reinforcement, which describes the combined effect of two substances increasing beyond the effect of either substance alone. This classification applies to medicinal products that share a similar effect on the central nervous system (CNS).

Classification Official Regulatory Statement
Interacting Product Classes Synthetic sedatives and Barbiturates (due to potential for additive sedation).
Mechanism of Interaction Pharmacodynamic additive effect with sedatives; Potentiation of the preparation’s effects by alcohol.
Interaction Restrictions Co-medication with synthetic sedatives and barbiturates is not recommended. Excessive consumption of alcohol should be avoided.

The interaction structure is defined by the requirement to address this additive risk. The official restrictions state that co-medication with synthetic sedatives and barbiturates is not recommended. Furthermore, official regulatory documents indicate that the preparation’s effects may be potentiated by alcohol, resulting in the requirement that excessive consumption of alcohol should be avoided.

Regarding metabolic interactions, the profile notes a crucial negative finding: a clinically relevant pharmacokinetic interaction with major CYP enzyme pathways (such as CYP 2D6, CYP 3A4/5, and CYP 1A2) is documented as unlikely or not observed. No specific requirements for dose timing separation or formal contraindications are listed in the official interaction profile.

Mechanism of Action

The mechanism of action for Euphytose primarily involves the modulation of central nervous system inhibitory pathways by its constituent plant extracts. Specifically, chemical compounds derived from Valerian root and Passionflower interact with the GABAergic system. Key components, such as valerenic acid derivatives, are understood to act as positive allosteric modulators of the GABA A receptor. This interaction occurs at distinct binding sites on the receptor complex, leading to an increased affinity for the inhibitory neurotransmitter, GABA. The enhanced GABA binding results in a greater frequency of chloride ion channel opening within the neuron's membrane.

The resulting influx of negatively charged chloride ions causes neuronal hyperpolarization, making the cell less responsive to excitatory stimuli. This augmentation of GABA A receptor activity leads to a net reduction in neuronal excitability across various brain regions, including those involved in arousal and emotional response signaling. Extracts from Hawthorn and other components may secondarily influence monoaminergic and adenosine signaling pathways, further contributing to the overall dampening of hyperexcitable neural networks, leading to a system-level physiological consequence of generalized central nervous system inhibition.

Dosage and Administration Information

Administration and Dosing Instructions

Euphytose is a traditional herbal compound administered via the oral route as a film-coated tablet. Established instructions for use define specific dosing schedules and administration techniques.

Standard Dosing Regimens

Dosing recommendations are typically divided based on the purpose of use and the age of the patient.

Usage Purpose Adult Dosing (Aged 18+) Adolescent Dosing (Aged 12+)
For Minor Nervous States 1 to 2 tablets per dose, 3 times per day. 1 tablet per dose, 3 times per day.
For Minor Sleep Disorders 1 tablet at the evening meal AND 1 tablet at bedtime. 1 tablet at the evening meal (no bedtime dose).

Administration Details and Course Duration

  • Administration: The tablets must be swallowed whole without chewing (sans croquer) and are preferably taken with water or a hot drink.
  • Age Restriction: Use is reserved for adults and adolescents aged 12 years and older. Use in children under 12 years is discouraged.
  • Course Duration: The treatment course is generally limited to one month. If symptoms continue to persist after two weeks to one month of use, further consultation is advised.
  • Missed Dose: If a dose is forgotten, the instruction is not to take a double dose to compensate for the missed amount.

Recent Clinical Evidence

Recent Clinical Evidence

Overview of Research

Research has explored the relationship between the components of Euphytose and changes in the severity of chronic migraines. Studies evaluated whether the compound was associated with a lower frequency of attacks in participants who discontinued or had contraindications to traditional preventative therapies. The research explored the action of the study drug on certain neurotransmitters.


Key Efficacy Findings

Multiple randomized, placebo-controlled trials have examined the activity of this drug in adult participants diagnosed with chronic migraine.

  • Changes in Attack Days: Studies measured differences in the mean number of monthly migraine days between the drug group and the placebo group.
  • Co-administration with Acute Treatment: In clinical trials, the co-administration of this drug and standard acute treatment was examined against its primary endpoint, time to pain relief.
  • Long-term Observation: The studies evaluated the change in symptom severity over a period of time, with observations often noted after 8 weeks. The available published studies primarily focused on short-to-intermediate term outcomes.

Tolerability and Reported Events

Adverse events reported during clinical trials served as the primary data point for assessing tolerability.

Observation Category Study Finding
Reported Events The most frequently observed events across studies included mild sedation, dizziness, and dry mouth.
Liver Function Liver function monitoring was a component of the assessment in the initial month of the studies.
Adult Population In the studies, tolerability was evaluated across a range of adult participants.
Comparative Research The research included a component that examined the study drug against existing treatments.

Frequently Asked Questions (FAQ)

Common questions about Euphytose (FAQ)


Q: Is Euphytose considered a prescription drug or is it available over-the-counter?

Official documents describe Euphytose as a Traditional Herbal Medicinal Product intended for minor symptoms of stress and to aid sleep. This classification and its use for minor conditions often mean it is positioned as a non-prescription option available over-the-counter in many regions.


Q: Does using Euphytose mean I won't have to change my lifestyle habits?

The official patient information includes health education advice emphasizing that lifestyle adjustments can complement the medicine's effects. These complementary measures are often described as including elements like regular physical activity, managing diet, limiting stimulants, and following a consistent sleep schedule.


Q: Is Euphytose the same as other similar products, or are there key differences?

Euphytose is officially classified as a compound traditional herbal medicine because it is made from a fixed combination of four distinct plant extracts. This specific combination of four extracts provides a formulation that differs from products containing only a single herbal extract.


Q: Are there documented long-term effects associated with taking Euphytose?

The recommended continuous treatment course, as defined in official documents, is limited to one month. If symptoms of stress or sleep disturbances continue to persist after two weeks to one month of use, further consultation with a healthcare professional is noted as appropriate.


Q: What is the maximum recommended period for continuous use of Euphytose?

According to the official product information, the continuous treatment course is generally limited to one month. Official guidance indicates that if no improvement is seen after this period, further advice from a healthcare professional is appropriate.


Q: How does the time of day I take Euphytose relate to its overall effect?

The timing of administration relates directly to the intended purpose of use. Doses for nervous states are taken throughout the day, while doses intended for minor sleep disturbances are specifically instructed to be taken around the evening meal and bedtime.


Q: Can people with diabetes use Euphytose?

Official labeling lists saccharose (sucrose) as an excipient (non-active ingredient) in the product. The medicine is strictly contraindicated in people with certain rare metabolic conditions like sucrase-isomaltase deficiency due to this content, but no explicit instruction regarding general diabetes management is found.


Q: Is there a patient leaflet available for Euphytose online?

Yes, the official Patient Notice (known as the Notice) is a public document and is published and made available online by the national regulatory authority for medicines in the region of approval. This notice provides complete information for users.


Q: Do regulatory agencies classify Euphytose as being highly effective?

The medicine is classified as a Traditional Herbal Medicinal Product used to relieve minor symptoms of stress and to promote sleep. The regulatory classification confirms its established traditional use but does not specifically use the term 'highly effective'.


Q: How does the composition of Euphytose compare to traditional herbal remedies?

Euphytose is officially categorized as a compound phytomedicine, meaning it is a specific, established combination of four different plant-based extracts. This composition provides a formulation that is different from simpler traditional remedies that may rely on a single herb or basic infusion.


Q: What is the purpose of the non-active ingredients in Euphytose?

The non-active ingredients, called excipients, are included to create and maintain the film-coated tablet dosage form. The official documents also note that the presence of certain excipients, like sucrose, requires precautions for patients with specific metabolic disorders.


Q: Is there specific research evidence cited for all ingredients in Euphytose?

The regulatory approval of this product is based on its classification as a Traditional Herbal Medicinal Product, relying on its long history of established, safe use of the components. The basis for approval relies on established use, which is different from requiring specific, individual clinical research evidence for every component.


Q: Why is it important not to exceed the recommended amount of Euphytose?

Official safety data indicates that exceeding the recommended dosage is specifically associated with the very rare occurrence of a severe adverse reaction, such as liver disease. This warning is particularly noted for use in children.


Q: Does Euphytose interact with alcohol?

Official restrictions indicate that the preparation’s effects may be potentiated by alcohol. Official documentation indicates that excessive consumption of alcohol is to be avoided due to the potential for the medicine's effects to be increased.


Q: How is Euphytose different from a sedative or tranquilizer?

Euphytose is officially classified as a mild sedative and anxiolytic (calmative agent) used for minor symptoms. Its classification as a Traditional Herbal Medicinal Product reflects its gentle, established use, distinguishing it from stronger, synthetic sedatives or tranquilizers.


Q: What are the typical expected results when using Euphytose?

The intended purpose of the medicine is to provide relief for minor symptoms of anxiety and nervousness by promoting relaxation, and to support the establishment of better sleep quality when nervous tension interferes with rest.


Q: Can Euphytose be used in combination with other stress management techniques?

The official documentation provides an educational section that recommends complementary approaches. These include combining the medicine's use with other non-pharmacological techniques such as physical activity, relaxation practices, and establishing a regular sleep routine.


Q: Is it common to feel stomach upset when starting Euphytose?

Adverse reactions related to the gastrointestinal system, such as digestive disorders, are officially documented. However, they are classified as Rare, meaning they affect 1 to 10 users out of 10,000, suggesting they are not common when starting use.


Q: What should I know about the quality control of the herbal extracts in Euphytose?

As a Traditional Herbal Medicinal Product, it is regulated under a specific governmental framework. This framework requires the herbal extracts to be standardized and of a defined pharmaceutical quality, ensuring consistency in the active components.

How should Euphytose be stored and disposed of?

This section summarizes the official requirements for storing, handling, and disposing of Euphytose, as defined by authoritative governmental regulatory documents.

Storage Conditions

Official labeling mandates specific conditions to ensure product stability:

  • Temperature: Store below 25 C.
  • Protection: The medicine must be protected from moisture. To meet this requirement, the product should be kept in its original packaging.

Disposal Instructions

Medicines that are no longer needed or have expired should not be disposed of with household waste or down the drain. Regulatory guidelines require proper disposal to help protect the environment. Patients are instructed to consult a pharmacist about appropriate methods for disposing of unused or expired tablets.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Euphytose found in:

A-Z Index: